Ronald W. Ellis

4.0k total citations
58 papers, 2.9k citations indexed

About

Ronald W. Ellis is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Ronald W. Ellis has authored 58 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Epidemiology, 14 papers in Molecular Biology and 11 papers in Immunology. Recurrent topics in Ronald W. Ellis's work include Herpesvirus Infections and Treatments (18 papers), Hepatitis B Virus Studies (10 papers) and Virus-based gene therapy research (9 papers). Ronald W. Ellis is often cited by papers focused on Herpesvirus Infections and Treatments (18 papers), Hepatitis B Virus Studies (10 papers) and Virus-based gene therapy research (9 papers). Ronald W. Ellis collaborates with scholars based in United States, Canada and United Kingdom. Ronald W. Ellis's co-authors include Paul M. Keller, Edward M. Scolnick, Robert S. Lowe, Deborah DeFeo, William J. Miller, Andrew J. Davison, Emilio A. Emini, Robert J. Gerety, Loren D. Schultz and B. J. Neff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Applied Physics.

In The Last Decade

Ronald W. Ellis

58 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ronald W. Ellis United States 31 1.6k 787 524 475 469 58 2.9k
Shigeharu Ueda Japan 30 1.2k 0.8× 837 1.1× 700 1.3× 607 1.3× 453 1.0× 137 2.9k
Kevin Anderson United States 32 1.9k 1.2× 843 1.1× 444 0.8× 1000 2.1× 585 1.2× 86 3.1k
Philip R. Krause United States 33 2.2k 1.4× 680 0.9× 751 1.4× 642 1.4× 500 1.1× 93 3.4k
Mette Strand United States 40 771 0.5× 1.4k 1.7× 1.1k 2.0× 460 1.0× 798 1.7× 121 4.7k
H. S. Marsden United Kingdom 37 3.0k 1.9× 874 1.1× 864 1.6× 310 0.7× 1.0k 2.2× 96 3.8k
Rae Lyn Burke United States 37 2.5k 1.6× 991 1.3× 968 1.8× 351 0.7× 843 1.8× 59 3.8k
June D. Almeida United Kingdom 30 1.3k 0.8× 358 0.5× 290 0.6× 1.1k 2.2× 385 0.8× 93 2.9k
G. D. Hsiung United States 31 2.2k 1.4× 609 0.8× 556 1.1× 963 2.0× 800 1.7× 181 3.7k
D. Neumann‐Haefelin Germany 29 1.3k 0.8× 452 0.6× 373 0.7× 538 1.1× 590 1.3× 84 2.4k
Roland Sahli Switzerland 30 1.1k 0.7× 1.0k 1.3× 334 0.6× 770 1.6× 537 1.1× 68 3.9k

Countries citing papers authored by Ronald W. Ellis

Since Specialization
Citations

This map shows the geographic impact of Ronald W. Ellis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald W. Ellis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald W. Ellis more than expected).

Fields of papers citing papers by Ronald W. Ellis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald W. Ellis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald W. Ellis. The network helps show where Ronald W. Ellis may publish in the future.

Co-authorship network of co-authors of Ronald W. Ellis

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald W. Ellis. A scholar is included among the top collaborators of Ronald W. Ellis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald W. Ellis. Ronald W. Ellis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ellis, Ronald W.. (1999). New technologies for making vaccines. Vaccine. 17(13-14). 1596–1604. 48 indexed citations
2.
Ellis, Ronald W. & Kenneth R. Brown. (1997). Combination Vaccines. Advances in pharmacology. 39. 393–423. 4 indexed citations
3.
Clark, H. F., Paul A. Offit, Ronald W. Ellis, et al.. (1996). The Development Of Multivalent Bovine Rotavirus (Strain Wc3) Reassortant. The Journal of Infectious Diseases. 174(Supplement 1). S73–S80. 157 indexed citations
4.
Donnelly, John, et al.. (1996). Protection against Papillomavirus with a Polynucleotide Vaccine. The Journal of Infectious Diseases. 173(2). 314–320. 139 indexed citations
5.
Schultz, Loren D., Henry Z. Markus, Kathryn J. Hofmann, et al.. (1994). Using Molecular Genetics to Improve the Production of Recombinant Proteins by the Yeast Saccharomyces cerevisiae. Annals of the New York Academy of Sciences. 721(1). 148–157. 28 indexed citations
6.
Vella, Philip P. & Ronald W. Ellis. (1992). Haemophilus b Conjugate Vaccines. Vaccines. 20. 1–22. 11 indexed citations
7.
Przysiecki, Craig T., Joseph G. Joyce, Paul M. Keller, et al.. (1992). Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae. Protein Expression and Purification. 3(3). 185–195. 13 indexed citations
8.
White, C. J., Barbara J. Kuter, Catherine Hildebrand, et al.. (1991). Varicella Vaccine (VARIVAX) in Healthy Children and Adolescents: Results From Clinical Trials, 1987 to 1989. PEDIATRICS. 87(5). 604–610. 192 indexed citations
10.
Vella, Philip P. & Ronald W. Ellis. (1991). Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccines in Infant Rhesus Monkeys. Pediatric Research. 29(1). 10–13. 29 indexed citations
11.
West, David J., Gary Calandra, & Ronald W. Ellis. (1990). Vaccination of Infants and Children Against Hepatitis B. Pediatric Clinics of North America. 37(3). 585–601. 35 indexed citations
12.
Ahonkhai, Vincent I., L.J. Lukacs, Leslie Jonas, et al.. (1990). Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB): clinical evaluation.. PubMed. 85(4 Pt 2). 676–81. 39 indexed citations
13.
Cupps, Thomas R., Jay H. Hoofnagle, Ronald W. Ellis, et al.. (1989). In vitro immune responses to hepatitis B surface antigen (pre-S2 and S) following remote infection by hepatitis B virus in humans. Journal of Clinical Immunology. 9(3). 229–241. 4 indexed citations
14.
Emini, Emilio A., Ronald W. Ellis, William J. Miller, et al.. (1989). Protective effect of a synthetic peptide comprising the complete pres2 region of the hepatitis b virus surface protein. Journal of Medical Virology. 28(1). 7–12. 41 indexed citations
15.
Kniskern, Peter J., Arpi Hagopian, Diana Montgomery, et al.. (1989). The Application of Molecular Biology to the Development of Novel Vaccines. PubMed. 251. 83–98. 7 indexed citations
16.
Emini, Emilio A., et al.. (1989). Vero cell‐expressed Epstein‐Barr virus (EBV) gp350/220 protects marmosets from EBV challenge. Journal of Medical Virology. 27(2). 120–123. 23 indexed citations
17.
Emini, Emilio A., Melvin Silberklang, Loren D. Schultz, et al.. (1988). Antigenic analysis of the epstein-barr virus major membrane antigen (gp350/220) expressed in yeast and mammalian cells: Implications for the development of a subunit vaccine. Virology. 166(2). 387–393. 31 indexed citations
18.
Provost, P. J., Paul M. Keller, Hilton J. Klein, et al.. (1987). Successful infection of the common marmoset (Callithrix jacchus) with human varicella-zoster virus. Journal of Virology. 61(10). 2951–2955. 20 indexed citations
19.
Soike, Kenneth F., Paul M. Keller, & Ronald W. Ellis. (1987). Immunization of monkeys with varicella‐zoster virus glycoprotein antigens and their response to challenge with simian varicella virus. Journal of Medical Virology. 22(4). 307–313. 27 indexed citations
20.
Davison, Andrew J., C M Edson, Ronald W. Ellis, et al.. (1986). New common nomenclature for glycoprotein genes of varicella-zoster virus and their glycosylated products. Journal of Virology. 57(3). 1195–1197. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026